Overview
David Zumbro is an Ophthalmologist in Anchorage, Alaska. Dr. Zumbro is rated as an Advanced provider by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Central Serous Chorioretinopathy, and Retinal Vein Occlusion. Dr. Zumbro is currently accepting new patients.
His clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
3801 University Lake Dr, Anchorage, AK 99508
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Alaska Retinal Consultants
Matthew Guess is an Ophthalmologist in Anchorage, Alaska. Dr. Guess is rated as an Advanced provider by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Diabetic Retinopathy, Retinal Artery Occlusion, and Vitrectomy. Dr. Guess is currently accepting new patients.
Scott Limstrom is an Ophthalmologist in Anchorage, Alaska. Dr. Limstrom is rated as an Advanced provider by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Retinal Vein Occlusion, and Retinal Artery Occlusion. Dr. Limstrom is currently accepting new patients.
Alaska Retinal Consultants
Chad Bouchard is an Ophthalmologist in Anchorage, Alaska. Dr. Bouchard has been practicing medicine for over 16 years and is rated as an Advanced provider by MediFind in the treatment of Age-Related Macular Degeneration (ARMD). His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Retinal Artery Occlusion, and Diabetic Retinopathy. Dr. Bouchard is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Age-Related Macular Degeneration (ARMD)
- Central Serous ChorioretinopathyDr. Zumbro isAdvanced. Learn about Central Serous Chorioretinopathy.
- Geographic AtrophyDr. Zumbro isAdvanced. Learn about Geographic Atrophy.
- Late-Onset Retinal DegenerationDr. Zumbro isAdvanced. Learn about Late-Onset Retinal Degeneration.
- Retinal Artery OcclusionDr. Zumbro isAdvanced. Learn about Retinal Artery Occlusion.
- Retinal Vein OcclusionDr. Zumbro isAdvanced. Learn about Retinal Vein Occlusion.
- Experienced
- CataractDr. Zumbro isExperienced. Learn about Cataract.
- Choroid Plexus CarcinomaDr. Zumbro isExperienced. Learn about Choroid Plexus Carcinoma.
- Cone DystrophyDr. Zumbro isExperienced. Learn about Cone Dystrophy.
- Cone Rod Dystrophy Amelogenesis Imperfecta
- Cone-Rod DystrophyDr. Zumbro isExperienced. Learn about Cone-Rod Dystrophy.
- Diabetic RetinopathyDr. Zumbro isExperienced. Learn about Diabetic Retinopathy.